Turk Ilac Ve Serum Sanayi Anonim Sirketi reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TRY 306.1 million compared to TRY 253.57 million a year ago. Net income was TRY 23.32 million compared to TRY 46.93 million a year ago.
For the six months, sales was TRY 443.49 million compared to TRY 303.75 million a year ago. Net income was TRY 31.91 million compared to TRY 56.07 million a year ago. Basic earnings per share from continuing operations was TRY 0.197 compared to TRY 0.3467 a year ago.